HPV and precancerous lesions of the cervix
prev Tooltip
Bladder cancer and Photocure Technology™

Bladder cancer and Photocure Technology™

Based on our breakthrough photodynamic technology we have developed a unique product to aid in the diagnosis and management of non-muscle invasive bladder cancer.
Colon cancer
next Tooltip
This information is for healthcare professionals only

Main content

Bladder cancer products

Photocure has developed one product for the detection of bladder cancer. The brand name is Cysview® in the US, and Hexvix® in the rest of the world.
  • Cysview® - US only

    Cysview® - US only
    Cysview® is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. This product is available in the US only.
  • Hexvix® - brand name outside of the US

    Hexvix® - brand name outside of the US
    Hexvix® is an optical imaging agent used for detection of bladder cancer, such as carcinoma in situ, in patients with known bladder cancer or high suspicion of bladder cancer, based on e.g. screening cystoscopy or positive urine cytology.

Right column

  • Hexvix® Contact

    Margrete Goksøyr
    Margrete Goksøyr
    Global Brand Director Hexvix
    mg@photocure.no
  • Cysview® Contact

    Ambaw Bellete
    Ambaw Bellete
    Head, US Cancer Commercial Operations
    Tel: +1 (609) 759 6515
    info@photocure.com